Fluocinonide and Biktarvy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluocinonide (fluocinonide) and Biktarvy (bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate). Common drug interactions include anxiety among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Fluocinonide and Biktarvy. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.

What is Biktarvy?

Biktarvy has active ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 19,543 Biktarvy users. Check the latest studies of Biktarvy.

On Jul, 29, 2026

15 people who take Fluocinonide and Biktarvy together, and have interactions are studied.

Fluocinonide and Biktarvy drug interactions.

What are the common drug interactions of Fluocinonide and Biktarvy, by gender? *:

female:

Anxiety
Depression
Emotional distress
Pain
Arthralgia (joint pain)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Gait disturbance
Osteoporosis (bones weak and more likely to break)
Asthenia (weakness)
Bone density decreased

male:

Emotional distress
Pain
Glomerular filtration rate decreased
Nephropathy (damage to or disease of a kidney)
Drug eruption (adverse drug reaction of the skin)
Drug hypersensitivity
Dysstasia (difficulty in standing)
Gait disturbance
Hand dermatitis (hand infection of skin)
Muscle spasms (muscle contraction)

What are the common drug interactions of Fluocinonide and Biktarvy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anxiety
Depression
Emotional distress
Pain
Arthralgia (joint pain)
Bone density decreased
Osteopenia (a condition where bone mineral density is lower than normal)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Ankle fracture
Bone disorder

40-49:

n/a

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone loss
Chronic kidney disease
Emotional distress
Glomerular filtration rate decreased
Osteopenia (a condition where bone mineral density is lower than normal)
Pain
Renal failure (kidney dysfunction)
Bone density decreased

60+:

Chronic kidney disease
Nephropathy (damage to or disease of a kidney)
Rash papular (redness with papule)
Renal cyst (kidney cyst)
Renal impairment (severely reduced kidney function)
Abdominal pain
Back pain
Blood creatinine increased
Bone density decreased
Drug ineffective

What are the existing conditions these people have? *

Pain: 3 people, 20.00%
Hypersensitivity: 3 people, 20.00%
Indigestion: 3 people, 20.00%
Rashes (redness): 2 people, 13.33%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 13.33%
Pain In Extremity: 2 people, 13.33%
Depression: 2 people, 13.33%
Dyshidrotic Eczema (skin condition in which blisters develop on the soles of your feet and/or the palms of hands): 2 people, 13.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 13.33%
Blood Testosterone Decreased: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Fluocinonide and Biktarvy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously